The Indiana Health Information Exchange (IHIE) announced that its Quality Health First Program has enrolled more than 1,500 physicians in more than 50 communities
The Indiana Health Information Exchange (IHIE) announced that its Quality Health First Program has enrolled more than 1,500 physicians in more than 50 communities throughout Indiana to help improve screenings rates and to support the management of medical conditions such as diabetes, heart disease, asthma and breast cancer for nearly 1 million patients.
Patients needing these and other interventions are flagged in reports to their primary care physician, enabling the physician to make care decisions before, during and after patient visits. Participation is open to any primary care practice in Indiana, regardless of its size or number of physicians, and is not restrictive to practices that do not use electronic health records.
The reports are based on more than 3 billion pieces of clinical information, along with claims information. The program allows physicians to review and verify the data, and to reconcile missing or inaccurate data.
For care provided in 2009, Anthem Blue Cross Blue Shield of Indiana awarded bonus payments totaling $3.4 million to participating primary care physicians in Indiana based on improvements in overall patient health. The amount of bonus payments from Anthem for care delivered by participating physicians in 2010 is expected to exceed that amount.
In addition to Anthem, United Healthcare and Unified Group Services, Medicare and Medicaid all participate in the program.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
More Results for Nerandomilast Reported by BI, This Time for Progressive Pulmonary Fibrosis
February 15th 2025Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim reported positive results from a similar phase 3 trial assessing its PDE4B inhibitor as a treatment for progressive pulmonary fibrosis.
Read More